[在患有异常性肺纤维化 (IPF) 的患者中引起炎症]
Ivon Rodríguez-Rodríguez1, Brayan Leonardo Mesa-Gallo2, Yubely Rico-Puentes2
1Universidad Nacional de Colombia. ijrodriguez@unal.edu.co.
概括
异常性肺纤维化 (IPF) 与某些炎症性细胞因子的水平增加有关,特别是老年人中的英尔路金-4 (IL-4),干扰素- (INFy) 和英尔路金-6 (IL-6). 这表明免疫系统不平衡在IPF发育中的作用.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 老年病的医生 老年病的医生
背景情况:
- 异形性肺纤维化 (IPF) 是一种渐进的肺部疾病,65岁以上的个体患病率较高.
- 慢性炎症性疾病与非传染性疾病有关,特别是在老年人群中.
- 适应性免疫,特别是Th1/Th2淋巴细胞平衡,与IPF病原发生有关.
研究的目的:
- 在被诊断患有IPF的成年患者中研究特定的益炎性细胞因子的水平.
- 将IPF患者的细胞因子概况与健康的老年人进行比较.
主要方法:
- 从60岁以上的已确认患有IPF的成年患者中采集了外周血液样本.
- 血被分离,并使用细胞计数珠阵列 (CBA) 来量化促炎细胞因子.
- 从哥伦比亚肺病学基金会的伦理和研究委员会获得了道德批准.
主要成果:
- 被诊断为IPF的患者表现出高水平的介质素-4 (IL-4),干扰素- (INFy) 和介质素-6 (IL-6).
- 与健康的老年人对照组相比,观察到这些细胞因子增加.
结论:
- 这些发现表明,高IL-4,INFy和IL-6水平与老年人的IPF之间存在关联.
- 需要进一步的研究来识别与IPF相关的免疫性标记物,并了解免疫失调的作用.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Pneumonia II: Pathophysiology
261
The pathophysiology of pneumonia involves the following steps:
261
COPD: Pathogenesis and Clinical Features
265
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
265
Inflammation
53.4K
Overview
53.4K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
169
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
169


